Keeler Thomas Management LLC acquired a new stake in shares of Stryker Corporation (NYSE:SYK) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 19,858 shares of the medical technology company’s stock, valued at approximately $3,074,000. Stryker comprises about 2.8% of Keeler Thomas Management LLC’s investment portfolio, making the stock its 10th largest position.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. WFG Advisors LP boosted its position in Stryker by 1.6% during the second quarter. WFG Advisors LP now owns 2,041 shares of the medical technology company’s stock valued at $283,000 after purchasing an additional 32 shares during the last quarter. Advisory Services Network LLC raised its holdings in Stryker by 1.8% during the second quarter. Advisory Services Network LLC now owns 3,398 shares of the medical technology company’s stock valued at $472,000 after buying an additional 59 shares in the last quarter. Linscomb & Williams Inc. raised its holdings in Stryker by 1.2% during the second quarter. Linscomb & Williams Inc. now owns 10,486 shares of the medical technology company’s stock valued at $1,455,000 after buying an additional 121 shares in the last quarter. Cornerstone Capital Management Holdings LLC. raised its holdings in Stryker by 0.3% during the second quarter. Cornerstone Capital Management Holdings LLC. now owns 53,572 shares of the medical technology company’s stock valued at $7,434,000 after buying an additional 135 shares in the last quarter. Finally, Optimum Investment Advisors raised its holdings in Stryker by 4.5% during the second quarter. Optimum Investment Advisors now owns 3,475 shares of the medical technology company’s stock valued at $482,000 after buying an additional 150 shares in the last quarter. 74.71% of the stock is owned by hedge funds and other institutional investors.

In related news, VP William E. Berry, Jr. sold 1,306 shares of Stryker stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $164.42, for a total transaction of $214,732.52. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Graham A. Mclean sold 2,984 shares of Stryker stock in a transaction dated Monday, February 5th. The stock was sold at an average price of $160.53, for a total value of $479,021.52. Following the sale, the insider now directly owns 9,100 shares in the company, valued at $1,460,823. The disclosure for this sale can be found here. Insiders sold 16,840 shares of company stock worth $2,749,989 over the last quarter. 7.40% of the stock is currently owned by corporate insiders.

Several equities analysts have weighed in on the company. Needham & Company LLC restated a “hold” rating on shares of Stryker in a report on Wednesday, January 31st. Piper Jaffray Companies restated a “buy” rating and set a $170.00 target price on shares of Stryker in a report on Wednesday, January 31st. Citigroup restated a “market perform” rating and set a $165.00 target price (up from $156.00) on shares of Stryker in a report on Thursday, February 1st. They noted that the move was a valuation call. Robert W. Baird upgraded Stryker from a “neutral” rating to an “outperform” rating in a report on Friday, November 24th. Finally, Cantor Fitzgerald restated a “neutral” rating and set a $163.00 target price on shares of Stryker in a report on Friday, January 5th. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and fourteen have given a buy rating to the stock. Stryker presently has a consensus rating of “Hold” and a consensus target price of $162.50.

Stryker Corporation (SYK) opened at $151.22 on Monday. The company has a debt-to-equity ratio of 0.66, a current ratio of 2.29 and a quick ratio of 1.59. The company has a market capitalization of $56,653.36, a PE ratio of 56.43, a PEG ratio of 2.17 and a beta of 0.70. Stryker Corporation has a 12 month low of $122.78 and a 12 month high of $170.00.

Stryker (NYSE:SYK) last posted its quarterly earnings data on Tuesday, January 30th. The medical technology company reported $1.96 EPS for the quarter, topping analysts’ consensus estimates of $1.95 by $0.01. The business had revenue of $3.47 billion for the quarter, compared to analyst estimates of $3.42 billion. Stryker had a return on equity of 24.56% and a net margin of 8.20%. The firm’s revenue for the quarter was up 9.9% on a year-over-year basis. During the same period in the previous year, the company posted $1.78 earnings per share. research analysts predict that Stryker Corporation will post 7.12 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, April 30th. Stockholders of record on Thursday, March 29th will be paid a $0.47 dividend. The ex-dividend date is Wednesday, March 28th. This represents a $1.88 dividend on an annualized basis and a dividend yield of 1.24%. Stryker’s payout ratio is presently 70.15%.

WARNING: This news story was first posted by Watch List News and is owned by of Watch List News. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright legislation. The correct version of this news story can be accessed at https://www.watchlistnews.com/19858-shares-in-stryker-corporation-syk-purchased-by-keeler-thomas-management-llc/1861466.html.

Stryker Company Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.